e-SPACE Heart Failure 2022

Published: 19 October 2022

Views:
17323
Likes:
7

Views:
17323
Likes:
7
Share:

Now Playing
Part 1 | Session 10 of 13
Meet the expert: Hyperkalaemia in patients with heart failure – dreadful side effect or manageable condition? (Supported by an unrestricted educational grant from CSL Vifor)
Javed Butler, Ileana L Piña

Up Next
1h 2m 37s

Part 1 | Session 11 Plenary Session 5: Managing side effects of HF drugs
Mitja Lainscak, Ambarish Pandey, Faiez Zannad, Justin Ezekowitz, Ileana L Piña, Harriette Van Spall
37m 5s

Part 1 | Session 12 Meet the expert: Sex differences in advanced heart failure
Andrew JS Coats, Aditi Nayak
1h 1m 4s

Part 1 | Session 13 Plenary Session 6: How to manage the obese patient with HF
Antonio Ceriello, Naveed Sattar, Stefan Anker, Tammy Lyn Kindel, Andrew JS Coats, Jean-Philippe Minart

1h 2m 46s

Part 2 | Session 1 Plenary Session 7: New technologies to manage your patients
Vijay Chopra, Rishi Sethi, Friedrich Koehler, Jasper J Brugts, William T Abraham, Leor Perl
33m 44s

Part 2 | Session 2 Meet the expert: Unlocking the potential of baroreflex activation therapy (BAT) for HFrEF patients (Sponsored by an unrestricted grant from CVRx)
Stefan Anker, Marat Fudim
1h 4m 11s

Part 2 | Session 3 Plenary Session 8: New technologies to treat your patients
Sajid Ansari, Fadi Jouhra, Marat Fudim, Johann Bauersachs, William T Abraham, Thomas Thum
1h 9s

Part 2 | Session 4 Plenary Session 9: Comparing European and US recent guidelines
Stefan Anker, Paul A Heidenreich, Antoni Bayés-Genís, Biykem Bozkurt, Gerasimos Filippatos, John GF Cleland
46m 45s

Part 2 | Session 5 Satellite Symposim: Bridging the implementation gap in heart failure across the EF spectrum (Supported by an educational grant from AstraZeneca)
John JV McMurray, Biykem Bozkurt, Giuseppe Rosano, Stephen J Greene
1h 1m 38s

Part 2 | Session 6 Plenary Session 10: How to implement these GLS in ambulatory patients around the world
Katherine Tuttle, Mehmet Birhan Yilmaz, Petar M Seferovic, Sivadasanpillai Harikrishnan, Yuhui Zhang, Magdy Abdelhamid , Clara Saldarriaga, Hiroyuki Tsutsui
30m 11s

Part 2 | Session 7 Meet the expert: SGLT2 inhibition in patients with HFrEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance)
Ewa Jankowska, Daniela Tomasoni
1h 1m 4s

Part 2 | Session 8 Plenary Session 11: Managing the HF patient with valvular heart disease
Stephen J Greene, Mitja Lainscak, Gregg Stone, Horst Sievert, Harish Ramakrishna, Ralph Stephan von Bardeleben
31m 36s

Part 2 | Session 9 Meet the expert: Management of tricuspid regurgitation in heart failure (Supported by an unrestricted educational grant from Edwards Lifesciences)
Stefan Anker, Philipp Lurz
1h 1m 28s

Part 2 | Session 10 Plenary Session 12: Managing the patient with worsening and advanced HF
Maria Generosa Crespo-Leiro, Ovidiu Chioncel, Alanna Morris, Shelley Zieroth, John R Teerlink, Gerasimos Filippatos

1h 1m 14s

Part 1 | Session 1 Plenary Session 1: Implementing the 4 foundational therapies in clinical practice John J Atherton, Piotr Ponikowski, Mark Petrie, Gianluigi Savarese, Kieran Docherty

32m 48s

Part 1 | Session 2 Meet the expert: Emerging evidence across the spectrum of heart failure: new insights from the deliver trial (Supported by an educational grant from AstraZeneca) John JV McMurray, Rudolf A. de Boer

1h 22s

Part 1 | Session 3 Plenary Session 2: Managing your HF patients with comorbidities (part 1) Yuhui Zhang, David Sim, Giuseppe Rosano, Vijay Chopra, Béla Merkely, A John Camm

36m 21s

Part 1 | Session 4 Meet the expert: SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Maurizio Volterrani, Anja Sandek

29m 54s

Part 1 | Session 5 Meet the expert: Improving exercise capacity and quality of life in patients with heart failure – the role of intravenous iron therapy (Supported by an unrestricted educational grant from CSL Vifor) Andrew Sindone, Mahir Karakas

1h 1m 19s

Part 1 | Session 6 Plenary Session 3: Using SGLT2 in your patients: practical considerations Philippe Gabriel Steg, Shelley Zieroth, Milton Packer, Muthiah Vaduganathan, Cecilia Bahit , Subodh Verma

41m 26s

Part 1 | Session 7 Satellite Symposium: SGLT2 inhibition as foundational heart failure therapy: have we changed our practices? (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Andrew JS Coats, Shelley Zieroth, Stefan Anker, Daniela Tomasoni, Clara Saldarriaga

53m 32s

Part 1 | Session 8 Plenary Session 4: Managing your HF patients with comorbidities (part 2) Giuseppe Galati, Altamash Y Shaikh, Ewa Jankowska, George L Bakris, Stephan Von Haehling, Javed Butler

33m 53s

Part 1 | Session 9 Meet the expert: Best practice recommendations for the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Clara Bonanad Lozano , Aaron Wong

Average (ratings)

No ratings

Your rating

Overview

e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.

Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.

For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

e-SPACE Heart Failure 2022 would like to thank the following sponsors:

Learning Objectives

Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts

Target Audience

Heart Failure Specialists
General Cardiologists
General Practitioners (GPs)
Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day 1

13 sessions
Plenary Session 1: Implementing the 4 foundational therapies in clinical practice	Watch now
Meet the expert: Emerging evidence across the spectrum of heart failure: new insights from the deliver trial (Supported by an educational grant from AstraZeneca)	Watch now
Plenary Session 2: Managing your HF patients with comorbidities (part 1)	Watch now
Meet the expert: SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance)	Watch now
Meet the expert: Improving exercise capacity and quality of life in patients with heart failure – the role of intravenous iron therapy (Supported by an unrestricted educational grant from CSL Vifor)	Watch now
Plenary Session 3: Using SGLT2 in your patients: practical considerations	Watch now
Satellite Symposium: SGLT2 inhibition as foundational heart failure therapy: have we changed our practices? (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance)	Watch now
Plenary Session 4: Managing your HF patients with comorbidities (part 2)	Watch now
Meet the expert: Best practice recommendations for the management of hyperkalemia (Supported by an educational grant from AstraZeneca)	Watch now
Meet the expert: Hyperkalaemia in patients with heart failure – dreadful side effect or manageable condition? (Supported by an unrestricted educational grant from CSL Vifor)	Watch now
Plenary Session 5: Managing side effects of HF drugs	Watch now
Meet the expert: Sex differences in advanced heart failure	Watch now
Plenary Session 6: How to manage the obese patient with HF	Watch now

Part 2

Day 2

10 sessions
Plenary Session 7: New technologies to manage your patients	Watch now
Meet the expert: Unlocking the potential of baroreflex activation therapy (BAT) for HFrEF patients (Sponsored by an unrestricted grant from CVRx)	Watch now
Plenary Session 8: New technologies to treat your patients	Watch now
Plenary Session 9: Comparing European and US recent guidelines	Watch now
Satellite Symposim: Bridging the implementation gap in heart failure across the EF spectrum (Supported by an educational grant from AstraZeneca)	Watch now
Plenary Session 10: How to implement these GLS in ambulatory patients around the world	Watch now
Meet the expert: SGLT2 inhibition in patients with HFrEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance)	Watch now
Plenary Session 11: Managing the HF patient with valvular heart disease	Watch now
Meet the expert: Management of tricuspid regurgitation in heart failure (Supported by an unrestricted educational grant from Edwards Lifesciences)	Watch now
Plenary Session 12: Managing the patient with worsening and advanced HF	Watch now

Faculty Biographies

Javed Butler

Professor of Medicine

Dr Javed Butler is President, Baylor Scott and White Research Institute, Senior Vice President for the Baylor Scott and White Health and Professor of Medicine at the University of Mississippi, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure.

He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.

Prof Butler has authored more than 900 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals and has been cited numerous times in America’s Best Doctors list.

View full profile

Ileana L Piña

Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US.

Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of examining recovery after exercise which could be translated to an additional parameter that may better predict prognosis of outcomes. In addition, there was a R21 to NHLBI to examine Vitamin D levels as another predictor from the HF ACTION database.

Dr Ileana L Pina is an Editorial Board member of Cardiac Failure Review.

View full profile